Survival after Introduction of Adjuvant Treatment in Stage III Melanoma: A Nationwide Registry-Based study.

Hildur Helgadottir,Lars Ny,Gustav J Ullenhag,Johan Falkenius,Rasmus Mikiver,Roger Olofsson Bagge,Karolin Isaksson

Journal of the National Cancer Institute（2023）

引用 0|浏览1

暂无评分

摘要

In this nationwide, population and registry-based study, no survival benefit was detected in patients diagnosed before or after the implementation of adjuvant treatment in stage III melanoma. These findings encourage a careful assessment of the current recommendations on adjuvant treatment.

查看译文

关键词

adjuvant treatment,melanoma,registry-based

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要